There are currently no generic Vimpat (lacosamide) products available, as this medication is protected by patents. Once the first patent expires in August 2014, there may be several companies that manufacture a generic version of this drug. However, lawsuits or other patents for specific uses of Vimpat may extend or shorten the exclusivity period of this medication. Lacosamide is the "generic name" of Vimpat; it is not a "generic version" of the drug.
Is a Generic Version of Vimpat Available?Vimpat® (lacosamide) is a prescription seizure medication. It is only approved for use along with other seizure medications to treat partial-onset seizures in people age 17 years old and older.
Vimpat is manufactured by UCB, Inc. It is currently under the protection of patents that prevent any generic versions of Vimpat from being manufactured in the United States.